Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 149

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 149
---
 results are not necessarily indicative of the results that may be expected in the future.
The results of operations data for the nine months ended September 30, 2025 and September 30, 2024 have been derived from the condensed
consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

    For the Nine Months Ended  
    Variance 

    September 30,  2025  
    September 30,  2024  
    September 30,  2025  
    September 30,  2024 
  
    Expenses: 

    Research and development 
    $2,042,890  
    $291,655  
    $1,751,235  
     600%
  
    General and administrative 
     4,057,046  
     1,341,271  
     2,715,775  
     202%
  
    Total operating expenses 
     6,099,936  
     1,632,926  
     4,467,010  
     274%

    Loss from operations 
     (6,099,936) 
     (1,632,926) 
     (4,467,010) 
     274%

    Other Income (Expenses): 

    Interest income 
     33,627  
     138  
     33,489  
     24267%
  
    Gain (loss) on change in fair value of derivative liability 
     -  
     (53,257) 
     53,257  
     -100%
  
    Interest expense 
     (3,557) 
     (217,821) 
     214,264  
     -98%
  
    Gain on extinguishment of debt 
     -  
     951,868  
     (951,868) 
     -100%
  
    Other income 
     -  
     40,000  
     (40,000) 
     -100%
  
    Total other income (expenses), net 
     30,070  
     720,928  
     (690,858) 
     -96%

    Net (loss) income 
    $(6,069,866) 
    $(911,998) 
    $(5,